Clinical Research Directory
Browse clinical research sites, groups, and studies.
Theophylline, Versus Sumatriptan and Gabapentin in The Treatment of Post-Dural Puncture Headache
Sponsor: Tanta University
Summary
The aim of this study is to compare the safety and efficacy of theophylline, sumatriptan, and gabapentin in the treatment of post-dural puncture headache.
Official title: A Comparison Between Safety and Efficacy of Theophylline, Versus Sumatriptan and Gabapentin in The Treatment of Post-Dural Puncture Headache: A Prospective Randomized Double Blinded Study
Key Details
Gender
All
Age Range
21 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
75
Start Date
2024-12-01
Completion Date
2026-11-01
Last Updated
2026-04-07
Healthy Volunteers
No
Interventions
Theophylline
Patients included in this group will receive oral 150 mg theophylline anhydrous tablet (QuibronT/SR, 300 mg dividose tablet, SmithKline Beecham Egypt L.L.C) every 12 hours.
Sumatriptan
Patients included in this group will receive oral 25 mg sumatriptan succinate tablet (Sumigran 25, 25 mg tablet, Sigma pharmaceutical industries, Egypt) every 12 hours.
Gabapentin
Patients included in this group will receive 200 mg of gabapentin every 12 hours.
Locations (1)
Tanta University
Tanta, El-Gharbia, Egypt